Liderfen (Ibuprofen)

Ibuprofen in Liderfen works by reversibly inhibiting the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in peripheral tissues. This inhibition lowers prostaglandin production, which reduces pain signaling, inflammation, and swelling at the site where the product is applied.

The appropriate amount of Liderfen to apply is determined by the prescribing healthcare professional based on the severity of symptoms, the size of the treatment area, and individual patient factors. Patients should follow the specific instructions provided by their prescriber or the product label.

Safety of topical ibuprofen during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Liderfen with their healthcare provider to weigh potential risks and benefits.

To order Liderfen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After receiving the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Compared with oral NSAIDs, topical Liderfen delivers the active ingredient directly to the site of pain, which can provide effective local relief while minimizing systemic exposure and associated gastrointestinal or cardiovascular risks. It is also an alternative to other topical NSAIDs such as diclofenac gel, offering a different ibuprofen‑based formulation.

Liderfen should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain product stability.

Liderfen is applied externally to clean, dry skin over the painful or inflamed area. A thin layer is spread gently and massaged until absorbed. The frequency and duration of application should follow the prescriber's instructions, typically not exceeding the recommended amount or treatment period.

Serious risks, though rare, include severe allergic reactions such as Stevens‑Johnson syndrome, systemic gastrointestinal upset from excessive absorption, renal impairment, and cardiovascular events. Patients should seek immediate medical attention if they experience symptoms like widespread rash, swelling, difficulty breathing, or unexplained bruising.

Liderfen should be avoided by individuals with known hypersensitivity to ibuprofen or any component of the formulation, those with open wounds or infected skin at the intended application site, and patients taking systemic anticoagulants or high‑dose oral NSAIDs without medical supervision. Pregnant or breastfeeding women should consult a healthcare professional before use.